GENERIC HBV VIRAL LOAD VER 2.0
Monitor patients with chronic hepatitis B
Over 250 million people globally live with chronic hepatitis B, which can lead to liver disease and severe complications like cirrhosis or hepatocellular carcinoma.
Lifelong treatment aims to halt disease progression by stopping viral replication. Quantifying HBV DNA viral load is essential for assessing treatment in chronic hepatitis B patients.
Rapid and accurate quantification of the hepatitis B viral load
GENERIC HBV VIRAL LOAD VER 2.0 is a highly sensitive and accurate test for quantification of HBV DNA from plasma EDTA samples.
Automated extraction with the GenoXtract®, in combination with GXT NA Extraction kit VER 1.0, provides high quality nucleic acid extraction for optimal PCR performance.
GENERIC HBV VIRAL LOAD VER 2.0 can easily be implemented in the routine analysis workflow using existing laboratory equipment, as the commonly available thermocyclers are validated with the assay.
Particularly, the FluoroCycler® XT provides fully automated analysis with FluoroSoftware® XT-IVD generating results at a glance, in an easy-to-use, easy-to-interpret test report.
Features
- Target: S gene - Genotypes A to H
- Sample: EDTA plasma 500 µL
- Lower limit of quantification: 5 IU/ml
Validated Thermocyclers
- Hain Lifescience FluoroCycler® XT
- Hain Lifescience FluoroCycler® 96
- Bio-Rad CFX96™
- ThermoFisher Scientific Applied Biosystems 7500 Fast
- ThermoFisher Scientific QuantStudio™ 5DX
- Roche Lightcycler® 480 instrument II
Benefits
- Reliable: Encapsulated internal control from the extraction step
- Accurate: Quantification with 4 standards included in the assay
- Automated extraction: with GenoXtract® and ready-to-use cartridges
- Sensitive: very low LLOQ of 5 IU/ml
- Easy-to-use: validated on commonly available thermocyclers
- Results at a glance: with FluoroCycler® XT
- IVDR-Compliant
Learn more from the experts
Diagnostic tools for Hepatitis B screening, management and follow up - 23.10.2024
Importance of Hepatitis B viral load to trigger and monitor antiviral treatment for chronic HBV infection webinar – 21.06.2023
GenoXtract®, FluoroCycler® and FluoroSoftware® are registered trademarks of the Bruker group of companies.
Legal manufacturer: Hain Lifescience, Hardwiesenstrasse 1, 72147 Nehren, Germany
Read instructions for use and/or labelling of the product.
Please contact your local representative for availability in your country.
Not for sale in the USA, Brazil, Australia, Japan and Canada.
